Beijing Dongfang Baitai Biotechnology Co., Ltd
Beijing, China en.east-bt.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Beijing Dongfang Baitai Biotechnology Co., Ltd. is a biopharmaceutical company in Beijing engaged in the research, development, production, and sales of innovative biological drugs. It works on antibody-based medicines for malignant tumors, diabetes, autoimmune diseases, and other major diseases. The company is located in Beijing Economic-Technological Development Area and operates a research and industrialization platform for antibody therapeutics.
Beijing Dongfang Baitai Biotechnology Co., Ltd is based in Beijing, China, founded in 2011. It lists 10 services, including Antibody drug R&D, Monoclonal antibody development and Bispecific antibody development. It names GMP on its listing.
Services
Antibody drug R&D
Researches innovative antibody therapeutics across the drug discovery and development process.
Monoclonal antibody development
Develops monoclonal antibodies for therapeutic use.
Bispecific antibody development
Develops bispecific antibody drugs for disease treatment.
Antibody fusion protein development
Develops antibody fusion protein drugs.
ADC development
Develops antibody-drug conjugates for therapeutic applications.
Antibody humanization
Uses sequence alignment and structural homology modeling to generate humanized antibodies.
High-affinity antibody screening
Uses phage-display screening to identify high-affinity antibody molecules.
Engineered cell line construction
Builds high-expression engineered cell lines for antibody production and process development.
2 more services
- Process optimization
- Quality management
How to order from Beijing Dongfang Baitai Biotechnology Co., Ltd
They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- Antibodies
- Bispecifics
- Toxicology
- ADCs
- Process development
- Phage-display screening
3 more
- Antibody humanization
- Three-dimensional structural homology modeling
- QbD-based quality management
- Scale and capacity
- 3 × 2000L mammalian cell batch culture and purification production line
- 30 mu first-phase site
- More than 100 people team
- Therapeutic areas
- Malignant tumors
- Diabetes
- Autoimmune diseases
- Ophthalmic diseases
- Respiratory diseases
- Rheumatoid arthritis
3 more
- Psoriasis
- Ankylosing spondylitis
- Nasopharyngeal cancer
Instruments and platforms
- Cutting-edge analytical techniques
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Recombinant protein
- Vaccine
- Species and models
- Animal disease models
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: China, European Union, and FDA
Details
- Founded
- 2011
- Team
- More than 100 people
- Based in
- Beijing, China
- Serves
- China, international